Taro Pharmaceutical
TARO
#5303
Rank
HK$12.67 B
Marketcap
HK$337.13
Share price
0.00%
Change (1 day)
9.21%
Change (1 year)

EPS for Taro Pharmaceutical (TARO)

EPS in 2023 (TTM): HK$9.55

According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is HK$9.57. an increase over its 2022 EPS that were of HK$9.57.

EPS history for Taro Pharmaceutical from 2011 to 2023

Annual EPS

Year EPS Change
2023HK$9.570%
2022HK$9.572950%
2021HK$0.31-100.51%
2020-HK$62.06-222.45%
2019HK$50.68-18.02%
2018HK$61.8253.01%
2017HK$40.41-55.95%
2016HK$91.72-13.41%
2015HK$105.9236.92%
2014HK$77.3637.71%
2013HK$56.1821.15%
2012HK$46.3744.15%
2011HK$32.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.41 447.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.19 330.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.57-41.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.79-18.60%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.58 135.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$3.53-63.11%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel